Vericel Corporation reported a 7% increase in total net revenue for the third quarter of 2021, reaching $34.5 million compared to $32.3 million in the third quarter of 2020. Despite the revenue growth, the company experienced a net loss of $4.9 million, or $0.11 per share, a shift from the net income of $3.6 million, or $0.08 per share, reported in the same quarter of the previous year.
Total net revenue reached $34.5 million, a 7% increase compared to Q3 2020.
MACI net revenue was $23.9 million, while Epicel net revenue was $9.8 million.
Net loss was $4.9 million, or $0.11 per share, compared to a net income of $3.6 million, or $0.08 per share, in Q3 2020.
The company had approximately $119 million in cash and investments as of September 30, 2021.
Vericel expects total net revenue to increase 27%-30% to approximately $158-$161 million. Gross margin is now expected to be approximately 70%. Adjusted EBITDA margin is now expected to be approximately 22%. Estimated operating expenses of approximately $114 million.
Visualization of income flow from segment revenue to net income